Tuberculosis News and Research

Latest Tuberculosis News and Research

New, practical tool may help doctors to easily diagnose cachexia in cancer patients

About one third of cancer patients die because of cachexia - an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely with increased food intake.

7 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

TB bacteria can be divided into generalists and specialists, study finds

Tuberculosis (TB) is a major global public health problem. Treatment often takes many months and till this day there is no effective vaccine. Various TB bacterial strains exist globally, with different geographical spread. Only the so-called Lineage 4 occurs on all continents.

4 Nov 2016

WHO Trauma Care Checklist Programme leads to improvements in care for injured patients

Injury is responsible for more than 10 percent of the global burden of disease, killing more people each year than HIV, malaria and tuberculosis combined.

2 Nov 2016

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

In a study published online by JAMA, Rafael Harpaz, M.D., M.P.H., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues analyzed data from the 2013 National Health Interview Survey to estimate the prevalence of self-reported immunosuppressed adults in the United States.

31 Oct 2016

Scientists discover potential new target for protective vaccines against Chagas disease

Saint Louis University Center for Vaccine Development researchers have identified a potential new target for vaccines that activates a part of the immune system not previously known to be protective against Chagas disease, tuberculosis and AIDS, as well as other diseases.

25 Oct 2016

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed.

25 Oct 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

Study estimates impact of six common healthcare-associated infections

A study published today by PLOS Medicine, estimates the combined burden of six healthcare-associated infections as being higher than that of diseases such as influenza, HIV/AIDS and tuberculosis together.

19 Oct 2016

New discovery helps explain why HIV infection increases risk for active tuberculosis

The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.

18 Oct 2016

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets.

14 Oct 2016

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

13 Oct 2016

Tuberculosis News and Research

Latest Tuberculosis News and Research

New, practical tool may help doctors to easily diagnose cachexia in cancer patients

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

TB bacteria can be divided into generalists and specialists, study finds

WHO Trauma Care Checklist Programme leads to improvements in care for injured patients

Study estimates prevalence of self-reported immunosuppressed adults in the U.S.

Scientists discover potential new target for protective vaccines against Chagas disease

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Two leading non-profit organizations sign strategic affiliation to hasten drug development

Study estimates impact of six common healthcare-associated infections

New discovery helps explain why HIV infection increases risk for active tuberculosis

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

New research shows mother's milk helps baby to make copies of maternal immune cells

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

Antibody protection may help control infection caused by TB bacteria

TB Alliance announces release of new TB medicines for Kenyan children

First generation antibiotics show promise for tuberculosis therapy

GACD funds international research projects that aim to prevent, manage chronic lung diseases

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in